2019
DOI: 10.1016/j.msard.2019.05.020
|View full text |Cite
|
Sign up to set email alerts
|

Subclinical cochlear dysfunction in newly diagnosed relapsing-remitting multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
27
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(30 citation statements)
references
References 44 publications
2
27
0
1
Order By: Relevance
“…As previously demonstrated for other neurological diseases [ 27 , 33 ], our results confirm a potential cochlear impairment in migraineurs, occurring at synaptic level between MOC and OHCs and targeting CGRP activity. A subclinical cochlear discomfort and a concomitant detectable dysfunction of the OHCs by OAEs may represent the earliest sign of sensorineural damage in these patients, providing a powerful tool for the initial diagnosis and an opportunity to monitor disease course and treatment response over time.…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…As previously demonstrated for other neurological diseases [ 27 , 33 ], our results confirm a potential cochlear impairment in migraineurs, occurring at synaptic level between MOC and OHCs and targeting CGRP activity. A subclinical cochlear discomfort and a concomitant detectable dysfunction of the OHCs by OAEs may represent the earliest sign of sensorineural damage in these patients, providing a powerful tool for the initial diagnosis and an opportunity to monitor disease course and treatment response over time.…”
Section: Discussionsupporting
confidence: 90%
“…Nevertheless, our patients with migraine exhibited deficit in DPOAE suppression compared to healthy subjects, which points to migraine as a disorder affecting in general the peripheral structures and the medial OC efferent system’s integrity. Previous studies already analyzed the OAE suppression in migraineurs, but not using DPOAE-notable more sensitive to detect alteration especially in neuroinflammatory diseases [ 27 ]; moreover the previous studies have been conducted on small-sized sample. Although the total suppression amplitude was lower in the individuals with migraine, these alterations were significantly observed only in a subset of migraineurs, such as women with phonophobia at the selected frequencies of 1–1.5 kHz [ 7 ] or patients with vestibular migraine [ 28 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Sin embargo, el PEATC mostró la afectación subclínica de la vía auditiva conjuntamente con las emisiones otoacústicas. 25 Los PEM como batería de estudio han sido usados para pronosticar el curso de la EM y evaluar los efectos de diferentes tratamientos en la misma. 26,27 En el presente estudio se constató una correlación positiva entre la escala de discapacidad de la enfermedad y el puntaje global de los PEM sensoriales, lo que coincidió con lo reportado por otros autores durante estudios de seguimiento.…”
Section: Discusión De Los Resultadosunclassified
“…14 47 However, the third study found weaker responses in both TEOAEs and DPOAEs in PwMS compared with healthy controls. 21 Five studies performed PTA on PwMS to assess hearing levels. A total of 510 participants (265 PwMS and 245 healthy controls) were evaluated with PTA, sample size varied from 80 to 146 and age range was between 18 and 65 years.…”
Section: Ms and Auditory Functionmentioning
confidence: 99%